Function and survival of intrasplenic islet autografts in dogs

Diabetologia

Volumn 39, Issue 1, 1996, Pages 37-44

  Van Der Burg, M P M ^a,d   Guicherit, O R ^a   Jansen, J B M J ^b   Frolich M ^a   Lamers, C B H W ^a   Lemkes, H H P J ^a   Bruijn, J A ^a   Gooszen, H G ^c  

^a LEIDEN UNIVERSITY   (Netherlands)

^b RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Dog; Glucose dependent insulinotropic polypeptide; Islet of Langerhans; Metabolism; Pancreatic polypeptide; Transplantation

Indexed keywords

GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON; GLUCOSE; INSULIN; PANCREAS POLYPEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL TRANSPLANTATION; CONTROLLED STUDY; DIABETES MELLITUS; DOG; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; GRAFT SURVIVAL; LANGERHANS CELL; NONHUMAN; PRIORITY JOURNAL; SPLEEN;

EID: 0030053753     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00400411     Document Type: Article

References (36)

1. Hering BJ, Browatzki CC, Schultz A, Bretzel RG, Federlin KF (1993) Clinical islet transplantation - registry report, accomplishments in the past and future research needs. Cell Transplantation 2: 269-282
2. Alejandro R, Cutfield RG, Shienvold FL et al. (1986) Natural history of intrahepatic canine islet cell autografts. J Clin Invest 78: 1339-1348
3. Kaufman DB, Morel Ph, Field MJ, Munn SR, Sutherland DER (1990) Purified canine islet autografts: functional outcome as influenced by islet number and implantation site. Transplantation 50: 385-391
4. Warnock GL, Rajotte RV (1988) Critical mass of purified islets that induce normoglycaemia after implantation into dogs. Diabetes 37: 467-470
5. Warnock GL, Ao Z, Cattral MS, Dabbs KD, Rajotte RV (1992) Experimental islet transplantation in large animals. In: Ricordi C (ed) Pancreatic islet cell transplantation. R. G. Landes Company, Austin, pp 261-278
6. Schwartz TW (1983) Pancreatic polypeptide: a hormone under vagal control. Gastroenterology 85: 1411-1425
7. Van der Burg MPM, Guicherit OR, Frölich M, Scherft JP, Bruijn JA, Gooszen HG (1994) Impact of donor-related variables on islet isolation outcome in dogs. Diabetologia 37: 111-114
8. Van der Burg MPM, Guicherit OR, Frölich M et al. (1994) Assessment of islet isolation efficacy in dogs. Cell Transplantation 3: 91-101
9. Van der Burg MPM, Gooszen HG, Guicherit OR et al. (1989) Contribution of partial pancreatectomy, systemic hormone delivery and duct obliteration to glucose regulation in canine pancreas: importance in pancreas transplantation. Diabetes 38: 1082-1089
10. Kuzio M, Dryburgh JR, Malloy KM, Brown JC (1974) Radioimmunoassay for gastric inhibitory polypeptide. Gastroenterology 66: 357-364
11. Ebert R, Illmer K, Creutzfeldt W (1979) Release of gastric inhibitory polypeptide (GIP) by intraduodenal acidification in rats and humans and abolishment of the incretin effect of acid by GIP-antiserum in rats. Gastroenterology 76: 515-525
12. Van Suylichem PTR, Strubbe JH, Houwing H, Wolters GHJ, Van Schilfgaarde R (1994) Rat islet isograft function: effect of graft volume and transplantation site. Transplantation 57: 1010-1017
13. Kneteman NM, Warnock GL, Evans MG, Nason RW, Rajotte RV (1990) Prolonged function of canine pancreatic fragments autotransplanted to the spleen by venous reflux. Transplantation 49: 679-681
14. Gray DWR (1989) The role of exocrine tissue in pancreatic islet transplantation. Transplant Int 2: 41-5
15. Bonner-Weir S, Deery D, Leahy JL, Weir GC (1989) Compensatory growth of pancreatic β-cells in adult rats after short-term glucose infusion. Diabetes 38: 49-53
16. Montana E, Bonner-Weir S, Weir GC (1992) Beta-cell mass falls progressively when hyperglycemia persists after islet transplantation. Transplant Proc 24: 2996-2996
17. Jansson L, Korsgren O, Sandler S, Andersson A (1990) Influence of persistent hyperglycemia on transplanted pancreatic islets. Horm Metab Res 25[Suppl]:137-142
18. Ward WK, Bolgiano DC, McKnight B, Halter JB, Porte D (1984) Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. J Clin Invest 74: 1318-1328
19. Ward WK, Wallum BJ, Beard JC, Taborsky J, Porte D (1988) Reduction of glycemic potentiation: sensitive indicator of β-cell loss in partially pancreatectomized dogs. Diabetes 37: 723-729
20. Nauck MA, Siegel EG, Creutzfeldt W (1991) Prolonged maximal secretion of insulin secretion in healthy subjects does not provoke preferential release of proinsulin. Pancreas 6: 645-652
21. Ebert R (1990) Gut signals for islet hormone release. Eur J Clin Invest 20[Suppl 1]:S20-S26
22. Van der Burg MPM, Guicherit OR, Scherft JP, Lemkes HHPJ, Frölich M, Gooszen HG (1992) Postprandial perfor-mance after canine islet transplantation: the importance of gut factors. Neth J Med 41: 25A (Abstract)
23. Strubbe JH, Steffens AB (1993) Neural control of insulin secretion. Horm Metab Res 25: 507-512
24. Korsgren O, Andersson A, Jansson L, Sundler F (1992) Reinnervation of syngeneic mouse pancreatic islets transplanted into renal subcapsular space. Diabetes 41: 130-135
25. Madureira MLC, Adolfo A, Dias J, Sebe M, Carvalhais HA, von Hafe P (1985) Rcinnervation of the endocrine pancreas after autotransplantation of pancreatic fragments in the spleen of the dog: a morphofunctional study. World J Surg 9: 335-347
26. Weigle DS (1987) Pulsatile secretion of fuel-regulatory hormones. Diabetes 36: 764-775
27. Chou H, Ipp E (1990) Pulsatile insulin secretion in isolated rat islets. Diabetes 39: 112-117
28. Alejandro R, Mintz DH (1991) Persistence of oscillatory insulin secretion in denervated islet cell autografts. Transplantation 52: 574-576
29. Paolisso G, Salvatore T, Sgambato S, Torella R, Varricchio M, D'Onofrio F (1990) Metabolic effects of pulsatile insulin infusion in the elderly. Acta Endocrinol 123: 19-23
30. Finegood DT, Warnock GL, Kneteman NM, Rajotte RV (1989) Insulin sensitivity and glucose effectiveness in long-term islet-autotransplanted dogs. Diabetes 38[Suppl 1]:189-191
31. Botha JL, Vinik AI, Child PT (1978) Gastric inhibitory polypeptide in acquired pancreatic diabetes: effects of insulin treatment. J Clin Endocrinol Metab 47: 543-549
32. Creutzfeldt W, Ebert R (1986) The enteroinsular axis. In: Go VLW (ed) The exocrine pancreas. Raven Press, New York, pp 333-346
33. Owyang C. (1986) Endocrine changes in pancreatic insufficiency. In: Go VLW (ed) The exocrine pancreas. Raven Press. New York, pp 577-585
34. Dinneen S, Alzaid A, Turk D, Rizza R (1995) Failure of glucagon suppression contributes to postprandial hyperglycemia in IDDM. Diabetologia 38: 337-343
35. Sun YS, Brunicardi FC, Druck P et al. (1986) Reversal of abnormal glucose metabolism in chronic pancreatitis by administration of pancreatic polypeptide. Am J Surg 151: 130-140
36. Seymour NE, Brunicardi FC, Chaiken RL et al. (1988) Reversal of abnormal glucose production after pancreatic resection by pancreatic polypeptide administration in man. Surgery 104: 119-129